The words used in marketing can make two pathways sound more alike than they are. They should be compared clearly and without implying that a compounded drug is an FDA-approved generic or identical copy.
| Brand-name pathway | Compounded pathway |
|---|---|
| FDA-approved finished drug for specified uses | Patient-specific preparation that is not FDA-approved |
| May involve insurance, prior authorization, or manufacturer cash-pay programs | Usually self-pay through a telehealth and pharmacy arrangement |
| Standard manufacturer presentation and labeling | Concentration, container, and instructions can vary by pharmacy and prescription |
| Shortage and coverage can affect access | Availability is affected by changing compounding law and enforcement policy |
Important: Compounded drugs are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality before marketing in the same way it reviews approved drugs.
Questions to ask
Ask which pharmacy will dispense, whether the pharmacy is licensed for your state, how concentration and instructions are communicated, how cold-chain delivery works, and what the provider does if the package arrives warm or damaged.
Claims to avoid
Do not rely on marketing that calls a compounded preparation a generic version, says it is FDA-approved, or implies it is the same as a named approved drug. Evaluate the actual prescription and pharmacy information.
Related tools
Use the provider matcher · Compare providers · Calculate true cost